tolvaptan has been researched along with Complications of Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, K; Furuta, S; Hiramatsu, T; Hobo, A; Ozeki, A; Saka, M | 1 |
| Bonow, RO; Fought, AJ; Gheorghiade, M; Huffman, M; Konstam, M; Kwasny, MJ; Maggioni, AP; Mentz, RJ; Nodari, S; Sarma, S; Subacius, H; Swedberg, K; Zannad, F | 1 |
2 trial(s) available for tolvaptan and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
The Vasopressin 2 Receptor Antagonist Tolvaptan Improves Nutrition and Inflammatory States in Peritoneal Dialysis Patients with Diabetes Mellitus.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; C-Reactive Protein; Cohort Studies; Diabetes Complications; Female; Historically Controlled Study; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Peritoneal Dialysis; Tolvaptan | 2015 |
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cause of Death; Combined Modality Therapy; Comorbidity; Cross-Sectional Studies; Diabetes Complications; Diet, Diabetic; Disease Progression; Female; Follow-Up Studies; Heart Failure, Systolic; Hospitalization; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Patient Discharge; Proportional Hazards Models; Tolvaptan; Treatment Outcome | 2013 |